Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
and one more thing HOLD FOR DOLLARS
Bztg....The thing about senderos and others like him or her is that they can pick fundamentally good stocks but one never knows if that stock will get the buzz, Some stocks move that don't deserve to move and some that do go unnoticed. I know you bought and are down a bit. i don't think I would give up just yet..good luck
This may be why BNVI is moving up. A very good read.
Bionovo Menopause Drug MF101 Is Detailed in Key Journal: Endocrinology
12/6/2006 7:30:00 AM
Publication Highlights Major Potential Safety Advantages of Company's Lead Drug Candidate
EMERYVILLE, Calif., Dec 06, 2006 /PRNewswire-FirstCall via COMTEX/ -- Bionovo, Inc.'s ( BNVI ) paper describing the mechanism of action of MF101, the company's lead drug candidate for menopausal symptoms, has been published in Endocrinology, a journal published by The Endocrine Society. The paper titled "Selective activation of estrogen receptor beta transcriptional pathways by an herbal extract" details how MF101 is selective to the estrogen receptor beta (ER-b) and does not affect estrogen receptor alpha (ER-a). This is a significant milestone toward the development of safe and effective drugs for menopause since it has been shown that the increased risk of breast and uterine cancers is associated with ER-a activation and that ER-b blocks the growth promoting effects on breast cancer cells.
"The results of our studies have demonstrated that MF101's ER-b selective estrogens may be a safer alternative to alleviate symptoms of menopause than traditional estrogens," said Dale Leitman, M.D., Ph.D., Center for Reproductive Endocrinology, University of California, San Francisco and member of Bionovo's Scientific Advisory Board. "Our findings suggest that targeting the ER-b will not only preserve the anti-inflammatory action potentially responsible for combating hot flashes and osteoporosis but will also be devoid of the proliferative effects of estrogens used in hormone therapy that are responsible for causing cancer."
The current study demonstrated that ER-b selectivity by MF101 is not due to differential binding since MF101 binds equally to ER-a and ER-b, but instead, showed that MF101 produces a different conformation in ER-a from ER-b resulting in selective ER-b regulation. The study also demonstrated that MF101 did not activate the genes that mediate the increased risk of breast and uterine cancers caused by estrogens. This effect of MF101 was confirmed in a mouse breast cancer model.
"Today, people are more familiar with the issues associated with menopause than ever before, because the life expectancy of women has risen dramatically over the past several decades. The results of the Women's Health Initiative (WHI) trial have shown that traditional hormone therapy increases the risks for breast cancer, strokes, heart disease, dementia and blood clots and the data have left women with few safe options to alleviate their symptoms," said Mary Tagliaferri, M.D., co-founder and Chief Medical Officer, Bionovo. "The mechanism of action of MF101 suggests that it may provide women with relief from menopausal symptoms, such as hot flashes and night sweats, while not compromising their overall health. Prior to the results of the WHI, the hormone therapy market was approximately $6.5 billion. With the baby boomers now transitioning into menopause, we expect the market size of those women looking for a safe and effective solution to grow dramatically."
MF101 is currently in Phase 2 clinical testing at six clinical sites throughout the country. The Principal Investigator for the Phase 2 trial is Dr. Deborah Grady, University of California, San Francisco. The Company anticipates that results from the Phase 2 trial will be available in the second quarter of 2007.
About Bionovo, Inc.
Bionovo is a drug development company focusing on the discovery of novel pharmaceutical agents for cancer and women's health. The company has two drugs in clinical testing. MF101 is in Phase 2 for quality of life conditions associated with menopause and BZL101 is in Phase 1/2 for the treatment of advanced breast cancer. The company has an additional pipeline of drugs in development for breast cancer, pancreatic cancer and other menopausal symptoms with a total of 5 drug candidates expected
also BNVI....I will stop here because I am on a DD mission today and I don't want to just throw too many out there. BNVI has just shot up. An interesting story. Again a new 52 week high...Now biotech is not my language but for someone who knows what they are looking at this may be a find...I am not reccing a buy. I am leaving that for more knowledgable people.
IPRE take a look at AESK when you have a chance. Trending up and .32 is the 52 week high. At first glance it looks like a stock to keep an eye on...but only because they are a property rich company. I post it just for your take on it or anyone else that may have a comment. GL
thanks for that information and until they do help us out the best way to succeed is to go long and close your eyes. GLTA
IPRE. I think you have the makings of a good board. I will only mention the best of the best that I find here. Good luck to you and all the visitors here.
where did you see flipper in my post..i am not trading..i am a holder long term gl
Very few people would even know what the heck to ask. I know I wouldn't. What would it matter. It still comes back to the deal. If it is what it is, what they do between now and a dollar down the road really only matters if you are trading. I am not so it is all very instructive but damn near irrelevant to me..gl
program traders buying and selling on cue and each time they do, strong hands pick them up and we inch forward
More flippers in this stock than I-Hop
I'm whistling dixie. sweet sounds
Raise your hand if you stole shares this morning
Well ladies there you go..
I like it and sometimes entertain the same numbers. We shall see. I will pass out cold if those numbers are in the financials. Like I said. Gulp!!!.GL
gulp!!!!
Jeff . Remember that the only trading shares post merger are the ones we hold and are in the current float. There has been no dillution throughout this 1 month bull run to the brink of the merger AS STATED OVER AND OVER AGAIN BY THE COMPANY. The trading behavior has validated the companies assertions.
Furthermore as you listen to the vermin that spread fear on the board, ask yourself that if the companies intent was to dillute their way to wealth post merger, why do they hold in such high regard their shares pre-merger. Why not start the presses now. Why not take advantage of one whole month of ABERRANT VOLUME. They could have made hundreds of thousands of dollars if not millions already. I will answer that for you. Because they know that hundreds of millions if not billions are at stake...Because they know that the common shareholder is a source of good will and that all people of integrity value the good will of their name ESPECIALLY when they are associated with such a HUGE GRASS ROOTS organization such as NASCAR. Please to all new comers here. Go back and read Mr. Trend Greens post....Beandog24, Klonopin, OBI. Click on their name and read, There are others.
Good luck to all and to all the bashers..DIE!
IEIB from digitrader on the Niz board
IPRE: It has a Very low float and nice revenues closed yesterday at $2.52. It will be interesting to see if it has a following. Avg daily volume is less than 10k shares. Yahoo states that 26% of float is held by insiders. No institutional holders as per yahoo and no recent insider trading.
(IEIB) - Reports Record Quarterly Revenues and Improved Net Profit
Last Update: 5:44 PM ET Jan 11, 2007
CANTON, Mass., Jan 11, 2007 (BUSINESS WIRE) -- International Electronics, Inc. (OTCBB symbol IEIB), a leading manufacturer of electronic access control and asset management products for industrial and commercial applications, today reported quarterly financial results for the first quarter of the fiscal year ending August 31, 2007. The company reported record quarterly revenues and continued improvement in operating profitability for the first quarter over each quarter of fiscal 2006.
Net sales for the three months ended November 30, 2006 were $4,301,353 versus sales of $3,368,960 in the same quarter of the prior year, an increase of 28%. Gross margins for the first quarter of fiscal 2007 improved 2% from the same quarter of the prior year from 43% to 45%. Operating profit for the first quarter of fiscal 2007 was $146,558 as compared with a loss of ($259,131) in the same quarter of fiscal 2006. The net income for the first quarter of fiscal 2007 was $126,534, or $.07 per diluted share as compared with a loss of ($256,400), or ($.15) per diluted share in the same quarter of fiscal 2006.
John Waldstein, President and CEO said, "We are encouraged by the continuing growth in revenues and profitability. We experienced important gains in the first quarter across our primary product lines, which includes eMerge(TM), our new browser managed security platform products, our core group of security products, as well as our PowerKey(TM) Fleet Management System. The accelerating pace of acceptance for eMerge products is especially gratifying. It reflects a rapidly developing market acceptance for our eMerge products and positive results from our ongoing strategy to train and certify a significant number of installing dealers."
Waldstein continued "Industry surveys continue to show strong growth in the access control market segment. We believe that the work we have done over the past several years positively positions IEI to continue to play an increasing role in that marketplace."
IPRE here is a tip I got from Lefty18 about CSBR
Geo, Have you checked out CSBR yet? It's another Reverse Merger - two prominent oncology docs just bought millions of shares. It looks like they're going to use it as a shell to begin a biotech company. The doc formerly of Imclone, now Johns Hopkins, has about 100 patents by himself.
The float is 7 million! It's currently at .19.
thanks portlander, maybe I will repost it but it might be better if someone else does, I think I have been iggy'd by some. Justifiably so. I have a big mouth..glty
Robertmic71 response to webprod on the BKMP board
"Looks like webprods was right again, not! Hmmm, what was he saying this will trade down .0001 x .0002 and something about the preferred shares going up? C'mon, they are not even trading and not affiliated with BKMP, yet. People do yourselves a favor and do not listen to this guy, he's funny, but hasn't been right about anything! JMHO "
We can regard his opinion in much the same light here. He just can't stand to see other people prosper because he hasn't the ability to put himself in the same position IGGY'D
the future is now... good luck. You will do very good here. Remember that the only trading shares post merger are the ones we hold and are in the current float. There has been no dillution throughout this 1 month bull run to the brink of the merger AS STATED OVER AND OVER AGAIN BY THE COMPANY. The trading behavior has validated the companies assertions.
Furthermore as you listen to the vermin that spread fear on the board, ask yourself that if the companies intent was to dillute their way to wealth post merger, why do they hold in such high regard their shares pre-merger. Why not start the presses now. Why not take advantage of one whole month of ABERRANT VOLUME. They could have made hundreds of thousands of dollars if not millions already. I will answer that for you. Because they know that hundreds of millions if not billions are at stake...Because they know that the common shareholder is a source of good will and that all people of integrity value the good will of their name ESPECIALLY when they are associated with such a HUGE GRASS ROOTS organization such as NASCAR. Please to all new comers here. Go back and read Mr. Trend Greens post....Beandog24, Klonopin, OBI. Click on their name and read, There are others.
Good luck to all and to all the bashers..DIE!
are we in play or what??!! another 20 million day
IPRE from the NIZ board
How many .ob stocks have $143M cash like UVIH? (suzananj )
applied for amex listing up 60% today. Probably an easy double from here. Look at what AOB did when it uplisted with far less cash in hand
he owns 12%of the float. he can play
we are now 5 up on them and thanks for that post.
I would love to know the answer to that myself. i remember someone posting that. I write that now because I feel the demand will start to outpace the available shares in greater distinction
half pennies soon..imo
that was nice
he iggy'd himself
now I have 2 iggy'd. should have iggy'd this one months ago glta...almost
VOlumE....is a thing of beauty
850k at .0049 glty
A lot of flippers who are not interested in the long term just a vehicle for flipping. They don't see it for what it really is. To them a pink is a pink is a pink. No differentiation skills. gl
they can't help themselves. If I see another 4, I will hunt them down
lefty, I am not a pd member so I can't answer a pm I will look at it. thanks a lot. I really appreciate the heads up..glty and everyone in FCCN
IPRE, trust me, You are the oasis. Remember, that there is dignity in all work and great peace of mind in a job well done. Sometimes the stocks and the chase distracts us from those things that really define a person value. Hard work, self respect and service among others. Good luck and enjoy the day to day struggle or all is lost
lot of missing numbers on the log here and considering I only have one person in all of I-hub on ignore. HMMMN Hey is there any way you can ignore someone twice. GO FCCN
IPRE look at what CXTI is doing. a great company
be brave. This is the real deal..good luck